Bld Pharmatech (India) Profile
Key Indicators
- Authorised Capital ₹ 1.10 M
- Paid Up Capital ₹ 1.02 M
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 69.16%
- Profit Growth -247.16%
- Ebitda -188.27%
- Net Worth -75.42%
- Total Assets 136.86%
About Bld Pharmatech (India)
Bld Pharmatech (India) Private Limited (BPIPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 30 July 2019 (Five years and six months 6 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.10 M and a paid-up capital of Rs 1.02 M, as per Ministry of Corporate Affairs (MCA) records.
Chandan Bhatera and Feng Wei serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U51909TG2019FTC134449
-
Company No.
134449
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
30 Jul 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Bld Pharmatech (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandan Bhatera
|
Additional Director | 07-Mar-2023 | Current |
Feng Wei
|
Director | 30-Apr-2021 | Current |
Financial Performance of Bld Pharmatech (India).
Bld Pharmatech (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 69.16% increase. The company also saw a substantial fall in profitability, with a 247.16% decrease in profit. The company's net worth observed a substantial decline by a decrease of 75.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bld Pharmatech (India)?
In 2023, Bld Pharmatech (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Hotgen Biotech India Private LimitedChandan Bhatera is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bld Pharmatech (India)?
Unlock and access historical data on people associated with Bld Pharmatech (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bld Pharmatech (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bld Pharmatech (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
